0001693601-16-000001.txt : 20161230 0001693601-16-000001.hdr.sgml : 20161230 20161230161522 ACCESSION NUMBER: 0001693601-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161230 DATE AS OF CHANGE: 20161230 EFFECTIVENESS DATE: 20161230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oppilan Pharma Ltd CENTRAL INDEX KEY: 0001693601 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-277436 FILM NUMBER: 162077746 BUSINESS ADDRESS: STREET 1: 3RD FLOOR STREET 2: 1 ASHLEY ROAD CITY: ALTRINCHAM STATE: X0 ZIP: WA14 2DT BUSINESS PHONE: 8589452393 MAIL ADDRESS: STREET 1: 3RD FLOOR STREET 2: 1 ASHLEY ROAD CITY: ALTRINCHAM STATE: X0 ZIP: WA14 2DT D 1 primary_doc.xml X0707 D LIVE 0001693601 Oppilan Pharma Ltd 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM X0 UNITED KINGDOM WA14 2DT 858-945-2393 UNITED KINGDOM None None Corporation true 2015 Christopher Krueger c/o Oppilan Pharma Limited 3rd Floor, 1 Ashley Road Altrincham X0 UNITED KINGDOM WA14 2DT Executive Officer Director Raju Mohan c/o Oppilan Pharma Limited 3rd Floor, 1 Ashley Road Altrincham X0 UNITED KINGDOM WA14 2DT Director Biotechnology Decline to Disclose 06b false 2016-12-16 false true false 0 12000000 4250000 7750000 $3Mil in new money; $500K in notes converted to Series A shares; $750K in notes converted to Series B shares false 5 0 0 0 false Oppilan Pharma Ltd /s/ Christopher Krueger Christopher Krueger Chief Executive Officer 2016-12-30